Oscient Pharmaceuticals Overview
- Year Founded
-
1961
- Status
-
Acquired/Merged
- Employees
-
316
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
- Investments
-
3
Oscient Pharmaceuticals General Information
Description
Developer of drugs for primary care physicians, cardiologists, endocrinologists and pulmonologists. The company primarily markets two products which are Antara and Factive. It also develops Ramoplanin for the treatment of Clostridium difficile-associated diseases.
Contact Information
Corporate Office
- 100 Beaver Street
- Suite 2200
- Waltham, MA 02453
- United States
Corporate Office
- 100 Beaver Street
- Suite 2200
- Waltham, MA 02453
- United States
Oscient Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oscient Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oscient Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Oscient Pharmaceuticals Investments & Acquisitions (3)
Oscient Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Oscient Pharmaceuticals (Antara Drug). The deal was made on 01-Jan-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Oscient Pharmaceuticals (Antara Drug) | 01-Jan-2006 | Corporate Asset Purchase | Buildings and Property | ||
| GeneSoft Pharmaceuticals | 06-Feb-2004 | Merger/Acquisition | Pharmaceuticals | ||
| Factive's North American Rights | 01-Apr-2003 | Corporate Asset Purchase | Buildings and Property |
Oscient Pharmaceuticals Exits (2)
Oscient Pharmaceuticals’s most recent exit was on 01-Jan-2006 from Oscient Pharmaceuticals (Antara Drug). The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Oscient Pharmaceuticals (Antara Drug) | 01-Jan-2006 | Completed |
|
||
| Factive's North American Rights | 01-Apr-2003 | Corporate Asset Purchase | Completed |
Oscient Pharmaceuticals FAQs
-
When was Oscient Pharmaceuticals founded?
Oscient Pharmaceuticals was founded in 1961.
-
Where is Oscient Pharmaceuticals headquartered?
Oscient Pharmaceuticals is headquartered in Waltham, MA.
-
What is the size of Oscient Pharmaceuticals?
Oscient Pharmaceuticals has 316 total employees.
-
What industry is Oscient Pharmaceuticals in?
Oscient Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Oscient Pharmaceuticals a private or public company?
Oscient Pharmaceuticals is a Private company.
-
What is Oscient Pharmaceuticals’s current revenue?
The current revenue for Oscient Pharmaceuticals is .
-
How much funding has Oscient Pharmaceuticals raised over time?
Oscient Pharmaceuticals has raised $124M.
-
Who are Oscient Pharmaceuticals’s investors?
Capital Ventures International, Domain Associates, Highbridge Loan (Collateralized Loan Obligation), LRG Capital, and Novartis Venture Fund are 5 of 6 investors who have invested in Oscient Pharmaceuticals.
-
When was Oscient Pharmaceuticals acquired?
Oscient Pharmaceuticals was acquired on 09-Sep-2009.
-
Who acquired Oscient Pharmaceuticals?
Oscient Pharmaceuticals was acquired by Chiesi USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
